Efficacy of the Cardiac Implantable Electronic Device Multisensory Triage-HF Algorithm in Heart Failure Care: A Real-World Clinical Experience

被引:0
|
作者
Aslan, Ugur [1 ]
Beeres, Saskia L. M. A. [1 ]
Feijen, Michelle [1 ]
Mulder, Gerlinde M. [1 ]
Jukema, J. Wouter [1 ,2 ]
Egorova, Anastasia D. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands
[2] Netherlands Heart Inst, Morseelsepk 1, NL-3511 EP Utrecht, Netherlands
关键词
cardiac implantable electronic device; multisensory algorithm; heart failure; telemonitoring; remote monitoring; RISK; HOSPITALIZATION; VALIDATION; MORTALITY; EVENTS; ALERTS;
D O I
10.3390/s24113664
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Heart failure (HF) admissions are burdensome, and the mainstay of prevention is the timely detection of impending fluid retention, creating a window for medical treatment intensification. This study evaluated the accuracy and performance of a Triage-HF-guided carepath in real-world ambulatory HF patients in daily clinical practice. In this prospective, observational study, 92 adult HF patients (71 males (78%), with a median age of 69 [IQR 59-75] years) with the Triage-HF algorithm activated in their cardiac implantable electronic devices (CIEDs), were monitored. Following high-risk alerts, an HF nurse contacted patients to identify signs and symptoms of fluid retention. The sensitivity and specificity were 83% and 97%, respectively. The positive predictive value was 89%, and negative predictive value was 94%. The unexplained alert rate was 0.05 alerts/patient year, and the false negative rate was 0.11 alerts/patient year. Ambulatory diuretics were initiated or escalated in 77% of high-risk alert episodes. In 23% (n = 6), admission was ultimately required. The median alert handling time was 2 days. Fifty-eight percent (n = 18) of high-risk alerts were classified as true positives in the first week, followed by 29% in the second-third weeks (n = 9), and 13% (n = 4) in the fourth-sixth weeks. Common sensory triggers included an elevated night ventricular rate (84%), OptiVol (71%), and reduced patient activity (71%). The CIED-based Triage-HF algorithm-driven carepath enables the timely detection of impending fluid retention in a contemporary ambulatory setting, providing an opportunity for clinical action.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Real-world clinical burden among patients with and without heart failure worsening after cardiac resynchronization therapy
    Chung, Eugene S.
    Rickard, John
    Lu, Xiaoxiao
    DerSarkissian, Maral
    Zichlin, Miriam L.
    Cheung, Hoi Ching
    Swartz, Natalia
    Greatsinger, Alexandra
    Duh, Mei S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (09) : 1489 - 1498
  • [32] Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting
    Nordberg Backelin, Charlotte
    Fu, Michael
    Ljungman, Charlotta
    ESC HEART FAILURE, 2020, 7 (03): : 1049 - 1055
  • [33] Catheter ablation for atrial fibrillation in patients with clinical heart failure: real-world experience from a tertiary centre
    Ines Aguiar Neves, A. I. Ana
    Teixeira, R.
    Leite, M.
    Nunes, F.
    Silva, M. Ribeiro
    Silva, G. Santos
    Almeida, M.
    Lobo, A.
    Almeida, J.
    Fonseca, P.
    Oliveira, M.
    Goncalves, H.
    Primo, J.
    Fontes-Carvalho, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 10 - 10
  • [34] Comparability Of The GALACTIC-HF Clinical Trial Population To Real-world Patients Having Heart Failure With Reduced Ejection Fraction
    Mefford, Matthew T.
    Koyama, Sandra Y.
    De Jesus, Justine
    Wei, Rong
    Fischer, Heidi
    Harrison, Teresa N.
    Woo, Pauline
    Reynolds, Kristi
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S11 - S12
  • [35] A CARDIOVASCULAR IMPLANTED ELECTRONIC DEVICE BASED HEART FAILURE RISK SCORE AND MORTALITY RISK IN A LARGE REAL-WORLD POPULATION OF PATIENTS
    Zile, Michael R.
    Koehler, Jodi
    Warman, Eddy
    Sarkar, Shantanu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1082 - 1082
  • [36] Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
    Tanaka, Atsushi
    Node, Koichi
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [37] Clinical application of sodium-glucose cotransporter 2 inhibitor into a real-world setting of heart failure care
    Atsushi Tanaka
    Koichi Node
    Cardiovascular Diabetology, 19
  • [38] Real-world experience of feasibility and efficacy of electrical muscle stimulation in elderly patients with acute heart failure: A randomized controlled study
    Arenja, Nisha
    Mueller, Christian
    Tomilovskaya, Elena
    Koryak, Yuri
    Poltavskaya, Maria
    Saner, Hugo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 344 : 113 - 119
  • [39] Real-World Disparities in Remote Follow-Up of Cardiac Implantable Electronic Devices and Impact of the Covid-19 Pandemic: A Single Center Experience
    Lehmann, H. Immo
    Sharma, Krishan
    Bhatia, Roma
    Li, Guoping
    Lang, Joshua
    Singh, Jagmeet
    Mela, Theofanie
    CIRCULATION, 2022, 146